Allergy Diagnostics and Therapeutics Market Analysis by Product by Allergen Type, by End-Use, by Test, by Drug Class and Segment Forecasts to 2022

Hexa Reports
Market Research Reports and Insightful Company Profiles

Allergy Diagnostics And Therapeutics Industry
Share and Size, Market Analysis, Trends and
Growth, End-use And Segment Forecasts To 2022

Global allergy diagnostics and therapeutics market is expected to reach USD 40.8 billion by 2022,
according to a new report by Grand View Research, Inc. Increasing prevalence of allergic conditions
and adoption of immunoassay as a viable diagnostic test is expected to serve this market with
lucrative future growth opportunities.
The prevalence of target diseases such as asthma and food allergies are expected to grow over the
next seven years, supported by sedentary and dietary lifestyle habits. In addition, rising indoor,
industrial pollution, rapid urbanization in developing countries and increasing greenhouse gas
concentrations are expected to increase the prevalence of pollen induced respiratory disorder,
thereby boosting the overall market growth over the forecast period.
Browse Detail Report With TOC @ http://www.hexareports.com/report/allergy-diagnosticmarket/details
Further key findings from the study suggest:
Consumables being an indispensable diagnostic product segment sell in large volumes and
therefore, dominated the market in 2014 with revenue share of over 55.0%. In addition, expensive
nature of reagents and their frequent application in diagnostic assay also supports the
aforementioned fact.
Increasing demand for analyzers and laminators for allergy diagnostics is expected to help this
segment grow at a lucrative CAGR of above 12.0% over the forecast period. Increasing awareness
pertaining to outsourcing of allergy testing services is anticipated to show upward shift in coming
years.
Increasing demand for minimally invasive and allergen specific tests is anticipated to serve in vitro
allergy diagnostics market with future growth opportunities. The market is expected to grow with
CAGR of above 12.0% over the forecast...